Compare CNTX & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTX | MBBC |
|---|---|---|
| Founded | 2015 | 1902 |
| Country | United States | United States |
| Employees | 15 | 35 |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5M | 43.4M |
| IPO Year | 2021 | N/A |
| Metric | CNTX | MBBC |
|---|---|---|
| Price | $0.59 | $15.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.60 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 21.4K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $47.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $9.96 |
| 52 Week High | $3.62 | $15.75 |
| Indicator | CNTX | MBBC |
|---|---|---|
| Relative Strength Index (RSI) | 20.39 | 63.55 |
| Support Level | N/A | $12.90 |
| Resistance Level | $1.30 | $15.55 |
| Average True Range (ATR) | 0.14 | 0.79 |
| MACD | -0.05 | 0.10 |
| Stochastic Oscillator | 3.80 | 96.41 |
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.